Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1632 participants
OBSERVATIONAL
2004-06-30
2021-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alberta Hip and Knee Replacement Project
NCT00277186
An Assessment of 4 Different Bearing Types in Hip Replacement Types to Analsye the Lowest Wear Rates of Polyethylene
NCT03900039
Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty
NCT01522014
A Comparison of a Resurfacing Hip System to Standard Total Hip Arthroplasty
NCT00253877
Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient
NCT00285948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard
Standard hip replacement subjects (polyethylene)
No interventions assigned to this group
Alternative Bearing
Subjects with ceramic on ceramic total hip replacement or metal on metal hip resurfacing.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient at least 18 years
* patient able to provide written consent
* Male under 65 years, female under 56 years
* Orthopedic surgeon has received appropriate training to implant an alternative device
Exclusion Criteria
* child bearing potential (MOM only)
* inappropriate femoral anatomy, including evidence of osteoporosis
* inflammatory arthritis (MOM)
* Unwilling to consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alberta Bone and Joint Health Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James MacKenzie, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Greg O'Connor, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alberta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alberta Bone and Joint Health Institute
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABHIP-00001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.